![Snehal Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 132 M $ in data 30/06/2026
Snehal S.
Patel is currently Director, Chief Executive & Financial Officer at Greenwich LifeSciences, Inc. since 2016 and has been with the company since 2010.
Mr. Patel is also VP-Operations at Welspun Corp.
Ltd. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The University of Chicago.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/07/2026 | 5.611.402 ( 38,23% ) | 132 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Amministratore Delegato | 01/06/2016 |
| WELSPUN CORP LIMITED | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Welspun Corp. Ltd.
 Welspun Corp. Ltd. Industrial MachineryProducer Manufacturing Manufactures steel pipes, coils and plates | Producer Manufacturing |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
